scout

OncLive

Articles by OncLive

The FDA has awarded a $600,000 grant for a phase I clinical trial of a genetically reprogrammed herpes simplex virus in young cancer patients with relapsed non-central nervous system (CNS) solid tumors such as sarcomas and neuroblastomas.

NCCN Launches Consumer-Friendly Versions of Guideline Publications Breast cancer and non-small cell lung cancer are the inaugural entries in a new series of publications the National Comprehensive Cancer Network (NCCN) is rolling out in the coming months.

Taking a Bow

California Researchers Receive Highest Honors From ASTRO Two prominent California-based radiation oncologists are the recipients of Gold Medal awards from the American Society for Radiation Oncology (ASTRO) this year.

Denosumab, a monoclonal antibody that has proved effective in preventing bone fractures and bone pain for patients whose cancer has metastasized and damaged the bone, won approval from the FDA after a 6-month priority review.

ColoPrint, a microarray-based gene signature test, accurately identifi ed the risk of recurrence of colorectal cancer in patients with localized stage II disease, raising the potential of an exciting new prognostic tool for clinicians.